Title : Impact of the specific mutation in KRAS codon 12 mutated tumors on treatment efficacy in patients with metastatic colorectal cancer receiving cetuximab-based first-line therapy: a pooled analysis of three trials.

Pub. Date : 2012

PMID : 22948721






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 An interaction model illustrated that KRAS p.G12C was associated with unfavorable outcome when treated with oxaliplatin plus cetuximab. Oxaliplatin KRAS proto-oncogene, GTPase Homo sapiens